Triaminic Vapor Patch Recall: side effect may cause seizures following use of children cough suppressant
6/19/2006 - Triaminic Vapor Patch recalled by Novartis after causing seizures in children
A cough suppressant vapor patch manufactured and sold for use by children as young as two (2) years old has been recalled after causing serious side effects including seizures. Many children have been removing the patch and placing it into their mouth. Chewing on the patch has led to seizures and other serious side effects.
The Triaminic Vapor Patch was manufactured and sold by Novartis specifically for use by young children. Directions called for patches to be placed on the child's chest or throat, allowing the vapors to reach the mouth and nose. However, since the patches were placed within easy reach, there were several reports of serious side effects after the patches were removed and chewed on by the child.
 |
In addition to causing seizures as a side efect of chewing on the Triaminic Vapor Patch, other symptoms include a burning sensation in the mouth, headaches, nausea and vomitting.
Novartis introduced the Triaminic Vapor Patch in 2000 and has reported sales of over 50 million units for the cough suppressant. The vapor patch was sold over the counter at stores nationwide in cherry and menthol until it was removed from the shelves on June 19, 2006.
Any remaining Triaminic Vapor Patch products should be discarded or returned to the store.
If you are aware of a child who has had a seizure following use of the Triaminic Vapor Patch cough suppressant, or experienced any side effects after removing the patch and chewing on it, they may have a claim. The Saiontz, Kirk & Miles lawyers in our dangerous medical product division have successfully pursued manufacturers of defective medications and products and can provide a free legal consultation.
